Document is current
Any future updates will be listed below
-
Authors
Lou, Yan-Ru https://orcid.org/0000-0001-7717-6010
Xu, Yu-Long https://orcid.org/0009-0003-5560-1102
Xiong, Yifeng
Deng, Chenhui
Wang, Qinghua
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03745885 at ClinicalTrials.govnct04314622 at ClinicalTrials.govDocuments that mention this clinical trial
Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes
https://doi.org/10.1007/s40262-025-01475-7
nct04994288 at ClinicalTrials.govDocuments that mention this clinical trial
Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes
https://doi.org/10.1007/s40262-025-01475-7
nct04998032 at ClinicalTrials.govDocuments that mention this clinical trial
Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes
https://doi.org/10.1007/s40262-025-01475-7
Documents that mention this clinical trial
Exposure–Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Treated with Metformin
https://doi.org/10.1007/s40262-025-01569-2
Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes
https://doi.org/10.1007/s40262-025-01475-7
- License Information
-
More Information
Article History
Accepted: 31 December 2024
First Online: 17 February 2025
Declarations
:
: This study was funded by Shanghai Innogen Pharmaceutical Technology Co., Ltd.
: Y.-R.L., Y.-L.X., and Q.W. are employees of Shanghai Innogen Pharmaceutical Technology Co., Ltd. Y.X. and C.D. are employees of Linking Truth Technology Co., Ltd.
: Y.-R.L. drafted the manuscript. Y.-L.X., Y.X., C.D., and Q.W. reviewed and edited the manuscript.
: All studies included in this analysis were approved by the relevant ethics committees and conducted in accordance with the principles of the Declaration of Helsinki and the International Council for Harmonisation guidelines for Good Clinical Practice (ICH-GCP).
: Data will be made available upon reasonable request, subject to the protection of research participants’ privacy.
